Harvard-Vision Clinical Scientist Development Program
The extraordinary
growth and specialization that has occurred over the past
several decades in the sciences has made it increasingly
difficult to link the increasing divide between clinical
and basic science components of ophthalmic and vision sciences.
The less-than-optimal degree of cross-talk between scientists
engaged in studying fundamental biological processes and
clinicians providing care to patients has had multiple deleterious
effects. Continued external factors are expected to impact
this trend negatively for the foreseeable future. Traditional
approaches, based purely on didactic curricula, to “teach”
basic sciences to highly-trained clinicians are only variably
effective as they offer limited opportunity to these clinicians
for hands-on experience in designing and conducting studies.
Additionally, many clinicians engaged in pure clinical (vs.
bench-based) research have had very limited formal training
in methodological aspects of clinical study design and execution.
To address these needs the Harvard-Vision Clinical Scientist Development Program is seeking to recruit and train clinician-scientists.We are seeking subspecialty/fellowship-trained board-certified/eligible ophthalmologists (or optometrists) to commit, at the level of Junior Faculty with 80% of their time dedicated to structured research and the development program under mentorship of one of our senior faculty. The duration of commitment will be 3-5 years based on the interests of the candidate and the nature of the mentored training program.
Two competitive positions are available throughout the Harvard Ophthalmology system for July 1 of each academic year. Application deadline for July 2008 position is October 31, 2007.
Download
an Application for the Academic year »
This program is funded by the National Institutes of Health.
For more information about the Harvard-Vision Clinical Scientist
Development Program, please contact Cori O’Brien at
(617)-573-3311 or
corio’
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Below, are tables listing the ophthalmic subspecialty areas,
and academic disciplines and related faculty, offered through
the Harvard-Vision Clinical Scientist Development Program.
Institution Key
Table 1 Subspecialty Areas
Harvard-Vision Clinical Scientist Development Program
|
Ocular Area of Concentration |
Mentors & Faculty (may be listed in >1 area of expertise) |
Institution |
|
|---|---|---|---|
| Tear Film & Ocular Surface | Darlene
A. Dartt, PhD Ilene Gipson, PhD David Sullivan, PhD James Zieske, PhD |
SERI SERI SERI SERI |
|
| Cornea & Anterior Segment | Kathryn
Colby, MD, PhD Reza Dana, MD, MSc, MPH Darlene A. Dartt, PhD Ilene Gipson, PhD |
MEEI & SERI MEEI & SERI SERI SERI |
|
| Glaucoma | Cynthia
Grosskreutz, MD, PhD Janey L. Wiggs, MD, PhD |
MEEI MEEI |
|
|
Reza Dana, MD, MSc, MPH | MEEI & SERI | |
| Ocular Microbiology | SERI MEEI & SERI |
||
| Pediatric Ophthalmology | David G. Hunter, MD, PhD | Children’s | |
| Nutrition & Disease Disease | Susan Hankinson, ScD, MPH Debra Schaumberg, ScD, MPH Johanna Seddon, MD |
HMS HMS Epidemiology MEEI |
|
| Low Vision | Eli
Peli, OD David G. Hunter, MD, PhD (pediatric) |
SERI Children’s |
|
| Ocular Oncology | Thaddeus
Dryja, MD Evangelos Gragoudas, MD |
MEEI MEEI |
| Retina | ||
| Physiology & Development |
Tiansen Li, PhD |
HU, Biological Lab MEEI MGH |
| Macular Degeneration | Evangelos
Gragoudas, MD Joan Miller, MD |
MEEI MEEI |
| Proliferative Vitreoretinopathy |
Lloyd Paul Aiello, MD, PhD Robert D’Amato, MD, PhD Patricia D’Amore, PhD Andrius Kazlauskas, PhD Mara Lorenzi, MD Joan Miller, MD Lois Smith, MD, PhD |
JDC Children's & MEEI SERI SERI SERI & MGH MEEI Children's |
| Inherited Retinopathies | Eliot Berson, MD Thaddeus Dryja, MD Tiansen Li, PhD |
MEEI MEEI MEEI |
Table 2 academic disciplines
Harvard-Vision Clinical Scientist Development Program
| Academic Discipline |
Mentors & Faculty (may be listed in >1 area of expertise) |
Institution | |
|---|---|---|---|
| Biostatistics & Epidemiology |
Robert
Glynn, ScD
|
BWH HMS Epidemiology MEEI HSPH |
|
| Clinical Trials |
Francis
Cook, ScD, MS
Robert Glynn,
ScD |
HMS, Clin. Effect. Prog. BWH MEEI
MEEI |
|
| Immunology & Microbiology | Reza Dana, MD, MSc, MPH Michael Gilmore, PhD |
MEEI &
SERI SERI |
|
| Physiology | Darlene Dartt, PhD Ilene Gipson, PhD David Hunter, MD, PhD David Sullivan, PhD James Zieske, PhD |
SERI SERI Children's SERI SERI |
|
| Development | John Dowling, PhD | HMS, Biological Labs | |
| Genetics | Eliot Berson, MD Thaddeus Dryja, MD Janey Wiggs, MD, PhD |
MEEI MEEI MEEI |
|
| Vascular & Endothelial Biology | Lloyd Paul Aiello, MD, PhD Patricia D’Amore, PhD Mara Lorenzi, MD Lois Smith, MD, PhD |
JDC SERI
SERI &
MGH |
|
| Matrix Remodeling & Angiogenesis | Lloyd Paul Aiello, MD, PhD Dimitri Azar, MD Patricia D’Amore, PhD Reza Dana, MD, MSc, MPH Joan Miller, MD |
JDC
MEEI &
SERI MEEI |
|
| Cell Biology | Ilene Gipson, PhD Cynthia Grossgreutz, MD, PhD Andrius Kazlauskas, PhD James Zieske, PhD |
SERI SERI SERI |
|
| Neurobiology |
John Dowling,
PhD
Tiansen
Li, PhD |
HMS, Biological Labs MEEI MGH |
|
| Optics | Eli Peli, OD | SERI |
